Abstract:The binary nanoassembly is self‐aggregated by DiR and EOE without the assistance of any carrier materials. After PEGylation and fibrin‐homing peptide modification, such a clot‐piercing nanoassembly prolonged blood circulation time and driven thrombus targeting accumulation, showing satisfactory thrombolytic effect and antiplatelet activity in an animal model of arterial thrombosis. Clinical thrombus therapy continues to be challenged by unsatisfactory antithrombotic outcomes and high bleeding risk. Rational design of prodrugs for thrombolytic agents is expected to ameliorate this situation. Nevertheless, a significant obstacle is the inadequate penetration of prodrugs and prodrug‐engineered nanomedicines, which hampers their effective interaction with the excessive stimuli produced in thrombi, resulting in suboptimal drug activation. Herein, a clot‐piercing nanoassembly is reported to facilitate photothermal clot penetration, adaptable drug activation, anti‐inflammatory action, and synergetic antithrombotic therapy, the nanoassembly is molecularly co‐assembled using a photothermal photosensitizer and a reactive oxygen species (ROS)‐sensitive antiplatelet dimeric prodrug. The nanoassembly demonstrates multiple advantages, including facile fabrication, high drug co‐loading capacity, long circulation time in the blood, thrombus‐targeting accumulation, photothermal‐potentiated clot‐piercing deep penetration, on‐demand prodrug activation in response to high H2O2 concentrations inside the clots, and anti‐inflammatory/antiplatelet synergy. These advantages result in significantly enhanced antithrombotic efficacy in vivo with favorable safety. This study presents a new paradigm for the development of prodrug‐driven antithrombotic nanomedicines.

Design and Characterization of Antithrombotic Nanoconjugate―m5k-BAD-L

Development Of Antithrombotic Nanoconjugate Blocking Integrin Alpha 2 Beta 1-Collagen Interactions

Development of antithrombotic nanoconjugate blocking integrin α2β1-collagen interactions

Inhibition of Arterial Thrombus Formation by Blocking Exposed Collagen Surface Using LWWNSYY-Poly(L-Glutamic Acid) Nanoconjugate

Development of the Antithrombotic Peptide LEKNSTY Targeting the Collagen Surface: I. Design and Validation

Design and characterization of antithrombotic ClEKnsTy-Au nanoparticles as diagnostic and therapeutic reagents

Biomimetic Design of Platelet Adhesion Inhibitors to Block Integrin Α2β1-Collagen Interactions: II. Inhibitor Library, Screening, and Experimental Validation.

Selective binding of cationic fibrinogen-mimicking chitosan nanoparticles to activated platelets and efficient drug release for antithrombotic therapy

Inhibition of Platelet Adhesion to Exposed Subendothelial Collagen by Steric Hindrance with Blocking Peptide Nanoparticles

Biomimetic Design of Platelet Adhesion Inhibitors to Block Integrin Α2β1-Collagen Interactions: I. Construction of an Affinity Binding Model

Synthesis, Nano-Features, Ex Vivo Anti-Platelet Aggregation and in Vivo Antithrombotic Activities of Poly-Α,β-dl-aspartyl-l-arginine

Self‐Actuated Clot‐Piercing Nanoassembly Enabling Adaptable Drug Activation and Synergistic Thrombus Ablation

A Erythrocyte-Platelet Hybrid Membrane Coated Biomimetic Nanosystem Based on Ginsenosides and PFH Combined with Ultrasound for Targeted Delivery in Thrombus Therapy.

Recombinant and Chemo-/Bio-orthogonal Synthesis of Liposomal Thrombomodulin and Its Antithrombotic Activity.

Development of the Antithrombotic Peptide LEKNSTY Targeting the Collagen Surface: II. Improvement of Plasma Stability.

Multiarm-Polyethylene Glycol-Polyglutamic Acid Peptide Dendrimer: Design, Synthesis, and Dissolving Thrombus.

Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy

Biomimetic nanoparticles co-deliver hirudin and lumbrukinase to ameliorate thrombus and inflammation for atherosclerosis therapy

Nanocomplexation of thrombin with cationic amylose derivative for improved stability and hemostatic efficacy

Structure-guided Creation of AcAP5-derived and Platelet Targeted Factor Xa Inhibitors

Synthesis and Evaluation of Cationic Polymeric Micelles As Carriers of Lumbrokinase for Targeted Thrombolysis